Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ELYSE JULIAN

Allopathic & Osteopathic Physicians Dermatology

NPI
1851743587
CMS profile
1508052
Location
PLANTATION, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$3,695.59

178 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $3,695.59 178

By paying entity

PY2025 · entire year · sorted by reported total

Page 4 of 4; records 151–178 of 178 matching records. This page contains 28 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ELYSE JULIAN

NPI 1851743587 · CMS profile ID 1508052

Allopathic & Osteopathic Physicians / Dermatology

PLANTATION, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–178 of 178 matching records. This page contains 28 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1851743587?year=2025&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ELYSE JULIAN, NPI 1851743587, CMS profile ID 1508052. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–178 of 178 matching records. This page contains 28 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1851743587?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ELYSE JULIAN, NPI 1851743587, CMS profile ID 1508052. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–178 of 178 matching records. This page contains 28 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1851743587?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ELYSE JULIAN, NPI 1851743587, CMS profile ID 1508052, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–178 of 178 matching records. This page contains 28 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1851743587?year=2025&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

178 matching records · $3,695.59 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 178 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–178 of 178.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
LEO Pharma Inc. $26.8803/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252014317 CMS
Verrica Pharmaceuticals Inc. $20.2303/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222326656 CMS
Lilly USA, LLC $23.7902/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186630911 CMS
Janssen Biotech, Inc. $25.4502/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175224113 CMS
Novartis Pharmaceuticals Corporation $18.9302/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200329480 CMS
ABBVIE INC. $24.2502/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202142407 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $24.0602/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250994534 CMS
ABBVIE INC. $20.7702/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202142405 CMS
GENZYME CORPORATION $47.5302/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233555166 CMS
STRATA Skin Sciences, Inc. $14.6202/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1253015124 CMS
Organogenesis Inc. $13.8502/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242022414 CMS
PFIZER INC. $22.5702/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229040878 CMS
Galderma Laboratories, L.P. $2.6402/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234659945 CMS
PFIZER INC. $21.9502/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229107230 CMS
Cipher Pharmaceuticals US LLC $25.7702/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1250594654 CMS
STRATA Skin Sciences, Inc. $15.1402/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1253015122 CMS
Biofrontera Inc. $21.6802/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1208905916 CMS
STRATA Skin Sciences, Inc. $5.7401/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1253015120 CMS
Janssen Biotech, Inc. $22.5001/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1175221381 CMS
Arcutis Biotherapeutics, Inc. $18.6801/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252340504 CMS
Incyte Corporation $30.3401/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1226050804 CMS
UCB, Inc. $23.8501/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224512942 CMS
GENZYME CORPORATION $16.3201/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233555146 CMS
Galderma Laboratories, L.P. $9.9901/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234659943 CMS
ABBVIE INC. $8.3301/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202142403 CMS
Organogenesis Inc. $22.5201/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1242022412 CMS
PFIZER INC. $15.3501/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229003014 CMS
LEO Pharma Inc. $11.1001/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1252014315 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,085.34 21
PY2020 $311.28 16
PY2021 $900.48 45
PY2022 $546.98 22
PY2023 $1,477.49 66
PY2024 $2,980.96 131
PY2025 $3,695.59 178

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,919.77 1
PY2025 Principal investigator $289,223.31 9
PY2024 Recipient $32,086.50 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

10 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 SANOFI PASTEUR INC. $2,050.00 12/24/2025 Non-covered Recipient Entity
Scla Management, Llc
A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age No dispute reported 06/30/2026 1226094103
Principal investigator 1 SANOFI PASTEUR INC. $384.78 10/10/2025 Non-covered Recipient Entity
Scla Management, Llc
A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age No dispute reported 06/30/2026 1226094097
Principal investigator 1 SANOFI PASTEUR INC. $55.26 10/07/2025 Non-covered Recipient Entity
Scla Management, Llc
A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age No dispute reported 06/30/2026 1226094092
Principal investigator 1 Eli Lilly and Company $652.40 07/28/2025 Non-covered Recipient Entity
SCLA MANAGEMENT LLC
EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) No dispute reported 06/30/2026 1187889976
Principal investigator 1 Eli Lilly and Company $146,312.48 07/21/2025 Non-covered Recipient Entity
SCLA MANAGEMENT LLC
A PHASE 4, MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO INVESTIGATE THE EFFICACY OF LEBRIKIZUMAB IN ADULT AND ADOLESCENT PARTICIPANTS WITH ATOPIC DERMATITIS WITH LIMITED BODY SURFACE AREA INVOLVEMENT AND HIGH ITCH BURDEN (ADSOLVE) No dispute reported 06/30/2026 1187889392
Principal investigator 1 Eli Lilly and Company $8,463.94 07/17/2025 Non-covered Recipient Entity
SCLA MANAGEMENT LLC
A PHASE 4, MULTICENTER, OPEN-LABEL, SINGLE-ARM STUDY TO INVESTIGATE THE EFFICACY OF LEBRIKIZUMAB IN ADULT AND ADOLESCENT PARTICIPANTS WITH ATOPIC DERMATITIS WITH LIMITED BODY SURFACE AREA INVOLVEMENT AND HIGH ITCH BURDEN (ADSOLVE) No dispute reported 06/30/2026 1187889394
Principal investigator 1 SANOFI PASTEUR INC. $8,075.00 05/23/2025 Non-covered Recipient Entity
Scla Management, Llc
A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age No dispute reported 06/30/2026 1226094080
Principal investigator 1 SANOFI PASTEUR INC. $7,425.45 05/23/2025 Non-covered Recipient Entity
Scla Management, Llc
A Phase I/II, Randomized, Placebo-controlled, Multi-arm, Dose-finding Study to Evaluate the Safety, Efficacy and Immunogenicity of an Acne mRNA Vaccine Candidate in Adults With Moderate to Severe Acne 18 to 45 Years of Age No dispute reported 06/30/2026 1226094086
Recipient Eli Lilly and Company $1,919.77 02/25/2025 Covered Recipient Physician EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) No dispute reported 06/30/2026 1187870975
Principal investigator 1 Eli Lilly and Company $115,804.00 01/21/2025 Non-covered Recipient Entity
SCLA MANAGEMENT LLC
EFFICACY AND SAFETY OF IXEKIZUMAB OR IXEKIZUMAB CONCOMITANTLY ADMINISTERED WITH TIRZEPATIDE IN ADULT PARTICIPANTS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS AND OBESITY OR OVERWEIGHT: A PHASE 3B, RANDOMIZED, MULTICENTER, OPEN-LABEL STUDY (TOGETHER-PSO) No dispute reported 06/30/2026 1187889004